Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Opiate Withdrawal Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Large-scale testing (Phase 3)Study completedNCT00235729
What this trial is testing

Lofexidine for Inpatient Opiate Detox

Who this might be right for
Opiate Addiction
US Department of Veterans Affairs 264
Early research (Phase 1)Study completedNCT03521960
What this trial is testing

Buspirone for Opioid Tapering

Who this might be right for
Opioid-Related DisordersDependency (Psychology)Pain, Chronic+1 more
Johns Hopkins University 18
Large-scale testing (Phase 3)Study completedNCT00032955
What this trial is testing

Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1

Who this might be right for
Heroin DependenceMorphine DependenceSubstance Withdrawal Syndrome
University of California, Los Angeles 163
Not applicableStudy completedNCT03971097
What this trial is testing

The Effect of Self-Forgiveness on Self-Stigma in Addiction.

Who this might be right for
Substance Use DisordersOpiate DependenceOpiate Withdrawal Syndrome+13 more
University of Pittsburgh 130
Not applicableWithdrawnNCT03975192
What this trial is testing

Neurostimulation for Opiate Withdrawal in the PICU

Who this might be right for
Opiate Withdrawal Syndrome
Medical College of Wisconsin
Testing effectiveness (Phase 2)Study completedNCT03608696
What this trial is testing

Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure

Who this might be right for
Neonatal Abstinence SyndromeNeonatal Opiate Withdrawal Syndrome
Thomas Jefferson University 10
Not applicableStudy completedNCT02643355
What this trial is testing

Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED

Who this might be right for
Substance Withdrawal Syndrome
Hennepin Healthcare Research Institute 70
Large-scale testing (Phase 3)Study completedNCT05980260
What this trial is testing

Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach

Who this might be right for
Neonatal Opiate Withdrawal Syndrome
HELP for NOWS Consortium 626
Post-approval studies (Phase 4)Ended earlyNCT01100437
What this trial is testing

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Who this might be right for
Chronic Pain
Pfizer 14
Early research (Phase 1)Study completedNCT02801357
What this trial is testing

Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction

Who this might be right for
Substance Withdrawal SyndromeOpiate AddictionOpiate Dependence
USWM, LLC (dba US WorldMeds) 10
Post-approval studies (Phase 4)Study completedNCT05569031
What this trial is testing

Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse

Who this might be right for
Opiate Withdrawal Syndrome
Zagazig University 52